دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Molecular and Functional Remodeling of Superior and Inferior SAN in a Rat Model of HCM
Anna Gams, P HD, a, * Jaclyn A. Brennan, PH D, a, * Katherine Goldrick, BS, a Igor R. Efimov, PH D
doi : 10.1016/j.jacep.2022.08.003
Volume 8, Issue 11, November 2022, Pages 1341-1353
Recently, our laboratory presented functional and molecular evidence for the presence of 2 competing sinoatrial node (SAN) pacemakers in healthy human and rat hearts.
The Inferior Sinoatrial Node Suffers the Most During Heart Failure∗
Nathan Grainger, PH D, a L. Fernando Santana, P HD
doi : 10.1016/j.jacep.2022.09.001
Volume 8, Issue 11, November 2022, Pages 1354-1356
Atrial Fibrillation Burden Specifically Determines Human Ventricular Cellular Remodeling
Thomas Körtl, MD,a Thea Stehle, MS C, a Dominic Riedl, BSC ,a Johanna Trausel, MS, a Sabine Rebs, P HD, b,c,d Steffen Pabel, MD,a Michael Paulus, MD,a Andreas Holzamer, MD, e Nassir Marrouche, MD,f Lars S. Maier, MD,a Christian Sohns, MD,g Katrin Streckfuss-Bömeke, PH D, b,c,d Samuel Sossalla, MD a
doi : 10.1016/j.jacep.2022.07.016
Volume 8, Issue 11, November 2022, Pages 1357-1366
Atrial fibrillation (AF) can either be a consequence or an underlying mechanism of left ventricular systolic dysfunction. Patients included in the CASTLE-AF (Catheter Ablation vs. Standard Conventional Treatment in Patients With LV Dysfunction and AF) trial who suffered from AF and left ventricular systolic dysfunction benefited from an AF burden <50% after catheter ablation compared with those patients with an AF burden >50%.
Atrial Fibrillation and Congestive Heart Failure: A Wicked Alliance About to Unravel∗
Alaa A. Shalaby, MD, MS C
doi : 10.1016/j.jacep.2022.08.015
Volume 8, Issue 11, November 2022, Pages 1367-1368
Increase in Cerebral Blood Flow After Catheter Ablation of Atrial Fibrillation
Yoshihide Takahashi, MD, P HD, a,b Tasuku Yamamoto, MD, a Jun Oyama, MD, P HD, c Genichi Sugihara, MD, PHD, d Yasuhiro Shirai, MD, a Susumu Tao, MD, P HD, a Masateru Takigawa, MD, PHD, a Hiroyuki Sato, PHD, e Masanao Sasaki, MS C,e Akihiro Hirakawa, PHD, e Hidehiko Takahashi, MD, PH D, d Masahiko Goya, MD, PH D, a Tetsuo Sasano, MD, PH D
doi : 10.1016/j.jacep.2022.07.011
Volume 8, Issue 11, November 2022, Pages 1369-1377
Recent studies have found that atrial fibrillation (AF) is a risk factor for cognitive impairment. Brain hypoperfusion is hypothesized as an underlying mechanism of cognitive decline in AF patients.
Rhythm Matters When It Comes to Brain Perfusion∗
T. Jared Bunch, MD, Benjamin A. Steinberg, MD, MHS
doi : 10.1016/j.jacep.2022.08.017
Volume 8, Issue 11, November 2022, Pages 1378-1380
Simultaneous Entrainment Response Assessment at Multiple Sites
Paweł Derejko, MD, PH D, a,b, * Piotr Podziemski, PHD, c, * Aleksander Bardyszewski, MD,b Paweł Kuklik, PHD, d Jacek Kusnierz, MD, b �ukasz Jan Szumowski, MD, P HD, a Katarzyna Ste ̨pien, MS, e Dobromiła Dzwonkowska, MD,b Magdalena Polanska-Skrzypczyk, MD, b Franciszek Walczak, MD, P HD, a Jan Jacek _Zebrowski, PHD, e Helmut Pürerfellner, MD
doi : 10.1016/j.jacep.2022.07.013
Volume 8, Issue 11, November 2022, Pages 1381-1390
“In or Out?�: New Insights Into Re-Entry Tachycardia∗
Jonathan Chrispin, MD
doi : 10.1016/j.jacep.2022.08.019
Volume 8, Issue 11, November 2022, Pages 1391-1392
Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors on Outcomes After Catheter Ablation for Atrial Fibrillation
Hideyuki Kishima, MD,a,b Takanao Mine, MD,a Eiji Fukuhara, MD,a Ryo Kitagaki, MD,a Masanori Asakura, MD, a Masaharu Ishihara, Mda
doi : 10.1016/j.jacep.2022.08.004
Volume 8, Issue 11, November 2022, Pages 1393-1404
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) have recently been a significant focus of attention because of their multiple pleiotropic effects. However, the impact of SGLT2i on atrial fibrillation (AF) remains unclear.
SGLT2 Inhibition and Atrial Fibrillation: Faint Light at the End of the Tunnel∗
Arwa Younis, MD, Oussama M. Wazni, MD, MBA
doi : 10.1016/j.jacep.2022.09.006
Volume 8, Issue 11, November 2022, Pages 1405-1406
Outcome of New-Onset Postoperative Atrial Fibrillation After Cardiac Surgery in Adults With Congenital Heart Disease
Alexander C. Egbe, MD, MPH,a William R. Miranda, MD,a Jason H. Anderson, MD, a Christopher V. DeSimone, MD, PHD, a Kartik Andi, MD,a Ahmed Y. Goda, MD,a Elizabeth H. Stephens, MD, PHD, b Joseph A. Dearani, MD,b Juan Crestanello, MD,b Heidi M. Connolly, MD, a Abhishek J. Deshmukh, MD
doi : 10.1016/j.jacep.2022.08.033
Volume 8, Issue 11, November 2022, Pages 1407-1416
Postoperative atrial fibrillation (POAF) is one of the most common complications after cardiac surgery. POAF is associated with a longer hospital stay, higher healthcare resource utilization, and higher risk of morbidity and mortality.
Temporal and Global Trends of the Incidence of Sudden Cardiac Death in Hypertrophic Cardiomyopathy
Omar M. Abdelfattah, MD, a Matthew Martinez, MD, b Ahmed Sayed, MD,c Mohamed ElRefaei, MD,c Abdelrahman I. Abushouk, MD,d Ahmed Hassan, MD,e Ahmad Masri, MD, f Stephen L. Winters, MD, g Samir R. Kapadia, MD,d Barry J. Maron, MD,h Ethan Rowin, MD,h Martin S. Maron, MD
doi : 10.1016/j.jacep.2022.07.012
Volume 8, Issue 11, November 2022, Pages 1417-1427
Since the initial clinical description of hypertrophic cardiomyopathy (HCM) over 60 years ago, sudden cardiac death (SCD) has been the most visible and feared complication of HCM.
Lessons We Learned About Sudden Death in Hypertrophic Cardiomyopathy∗
Josef Veselka, MD, PHD
doi : 10.1016/j.jacep.2022.08.021
Volume 8, Issue 11, November 2022, Pages 1428-1430
Conduction System Pacing vs Biventricular Pacing in Heart Failure and Wide QRS Patients: LEVEL-AT Trial
Margarida Pujol-Lopez, MD,a,b Rafael Jiménez-Arjona, MD, a Paz Garre, BE NG, a Eduard Guasch, MD, PH D, a,b,c Roger Borrà s, MS C,a,b,d Adelina Doltra, MD, P HD, a,b Elisenda Ferró, ME NG ,e,f Cora GarcÃa-Ribas, MD, P HD, a,f Mireia Niebla, RN,a Esther Carro, RN,a Jose L. Puente, MD, a Sara Vázquez-Calvo, MD,a Eric Invers-Rubio, BE NG ,b Ivo Roca-Luque, MD, PHD, a,b,c M. Ã�ngeles Castel, MD, PH D, a,b,c Elena Arbelo, MD, PH D, a,b,c Marta Sitges, MD, PHD, a,b,c Josep Brugada, MD, PHD, a,b,c José M. Tolosana, MD, P HD, a,b,c, * LluÃs Mont, MD, PHD
doi : 10.1016/j.jacep.2022.08.001
Volume 8, Issue 11, November 2022, Pages 1431-1445
Conduction system pacing (CSP) has emerged as an alternative to biventricular pacing (BiVP). Randomized studies comparing both therapies are scarce and do not include left bundle branch pacing.
LEVEL the Playing Field: Newer Options for Cardiac Resynchronization Therapy∗
Pugazhendhi Vijayaraman, MD, a Parikshit S. Sharma, MD, MPH b
doi : 10.1016/j.jacep.2022.08.027
Volume 8, Issue 11, November 2022, Pages 1446-1448
Feasibility of Computed Tomography-Guided Cardioneuroablation for Atrial Fibrillation
Timothy M. Markman, MD Mirmilad Khoshknab, MD Pasquale Santangeli, MD, PhD Francis E. Marchlinski, MD Saman Nazarian, MD, PhD
doi : 10.1016/j.jacep.2022.06.004
Volume 8, Issue 11, November 2022, Pages 1449-1450
Atrial Fibrillation Causes Decreased Cerebrovascular Reserve: A Controlled Experimental Study
Brian Zenger, PhD Eugene Kwan, MS Eugene Kholmovski, PhD Miriam E. Peckham, MD Benjamin A. Steinberg, MD, MHS Adam deHavenon, MD, MSCI Ravi Ranjan, MD, PhD *T. Jared Bunch, MD
doi : 10.1016/j.jacep.2022.06.008
Volume 8, Issue 11, November 2022, Pages 1451-1453
Safety of Oncologic Proton Beam Therapy in Patients With Cardiac Implantable Electronic Devices
Martin van Zyl, MD Yolanda I. Garces, MD Anvi Raina, MD Nicholas B. Remmes, PhD Sarah J. Schroeder, RN Sandra S.J. Anderson, RN Lynette G. Stuart-Mullen, APRN, CNS Debra H. Brinkmann, PhD David J. Bradley, MD, PhD *Yong-Mei Cha, MD
doi : 10.1016/j.jacep.2022.06.011
Volume 8, Issue 11, November 2022, Pages 1453-1455
ICE-Guided Ablation of RVOT-Type Arrhythmias: A Call for a New Classification
Francesco De Sensi, MD Ugo Limbruno, MD *Filippo Maria Cauti, MD
doi : 10.1016/j.jacep.2022.07.026
Volume 8, Issue 11, November 2022, Page 1455
Reply: ICE-Guided Ablation of RVOT-Type Arrhythmias: A Call for a New Classification
Sixian Weng, MD *Min Tang, MD, PhD
doi : 10.1016/j.jacep.2022.09.007
Volume 8, Issue 11, November 2022, Pages 1455-1457
The Fight Against Ablation Reimbursement Cuts
Rajesh Kabra, MD, FHRS, FACC, Member of the ACC EP Section Council,a Samuel Jones, MD, MPH, FHRS, FACC, Chair, ACC Health Affairs Committee, b Jim W. Cheung, MD, FHRS, FACC, Chair, ACC EP Section Council
doi : 10.1016/j.jacep.2022.09.008
Volume 8, Issue 11, November 2022, Pages 1458-1459
The Persistence of an Atrial Tachyarrhythmia Constrained to an Isolated Pulmonary Vein
Christopher C. Cheung, MD, MPH, Adam C.H. Lee, MBBS, Gregory M. Marcus, MD, MAS
doi : 10.1016/j.jacep.2022.05.016
Volume 8, Issue 11, November 2022, Pages 1460-1466
Hydroxychloroquine-Associated Cardiomyopathy With Midmyocardial Right Ventricular Tachycardia
Eric D. Braunstein, MD, David S. Olshan, MD, James K. Gabriels, MD, Zohaib Shaikh, MD, Bruce B. Lerman, MD, Jim W. Cheung, MD
doi : 10.1016/j.jacep.2022.06.020
Volume 8, Issue 11, November 2022, Pages 1467-1469
17th Annual International Symposium on Ventricular Arrhythmias: Pathophysiology & Therapy, New York City, October 7-8, 2022
doi : 10.1016/j.jacep.2022.10.027
Volume 8, Issue 11, November 2022, Pages 1470-1474
